MARTIN J TYLER 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 3, 2012
Insider Transaction Report
Form 4
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
- Award
Option (Right to Buy)
2012-02-01+400,000→ 400,000 totalExercise: $3.68Exp: 2022-01-31→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]This option grant shall vest over four (4) years with one fourth (1/4) of the Shares subject to the Option vesting twelve months after the Vesting Commencement Date, and one forty-eighth (1/48) of the Shares subject to the Option vesting on the last day of each month thereafter.
- [F2]Not applicable.